ARCHIVES

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions

July 10, 1987